Hosted on MSN5h
FDA approves 'ketamine' nasal spray for depression — here's everything you need to knowA nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment isn’t ...
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
Interesting Engineering on MSN1d
Sniffing out cancer: Scientists test nasal drug for deadly pancreatic tumorsA groundbreaking approach led by a team of scientists, including Rice University chemist James Tour, has the potential to ...
The “life-changing” drug, Acarizax, works by delivering a fixed amount of house dust mite allergy extract every day to help ...
The city has installed Narcan kits at public locations after receiving them as a donation from Mothers for Awareness and ...
The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...
People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
MDR Certification Strengthens Resyca’s Leadership in Soft Mist Drug-Device Combination Products ENSCHEDE, NL / ACCESS ...
The FDA has approved the use of Spravato, an antidepressant nasal spray, as a standalone treatment for depression in the U.S. Sue Varma discusses why she supports the use of the drug and how it may ...
School nurses, teachers or other people trained and qualified would be authorized to administer the nasal spray to a student or staff member experiencing symptoms of an opioid overdose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback